A phase 1b/2 study of azacitidine with PD-L1 antibody avelumab in relapsed/refractory acute myeloid leukemia

Kapil Saxena, Shelley M. Herbrich, Naveen Pemmaraju, Tapan M. Kadia, Courtney D. DiNardo, Gautam Borthakur, Sherry A. Pierce, Elias Jabbour, Sa A. Wang, Carlos Bueso-Ramos, Sanam Loghavi, Guillin Tang, Cora M. Cheung, Lynette Alexander, Steven Kornblau, Michael Andreeff, Guillermo Garcia-Manero, Farhad Ravandi, Marina Y. Konopleva, Naval Daver

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 1b/2 study of azacitidine with PD-L1 antibody avelumab in relapsed/refractory acute myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences